Decision No. 4819/2004/QD-BYT of the Ministry of Health stipulates a list of seven active substances and formulations not accepting new registration and re-registration applications for foreign drugs. This decision shall take effect fifteen days from the date of publication in the Official Gazette and replace the previous decision.
적용 범위
Vietnam National Pharmaceutical Administration, Departments under the Ministry of Health, Inspector General, Heads of units directly under the Ministry of Health, Directors of Provincial/Municipal Health Services, Heads of health sectors, and related units.
핵심 사항
- The Vietnam National Pharmaceutical Administration issues a list of seven active substances and formulations not accepting new registration and re-registration applications for foreign drugs.
- This list does not apply to drugs containing active substances invented by manufacturers.
- Drugs containing active substances listed herein shall not be accepted for registration as single substances or combinations; however, if there is clinical trial data proving the superiority of the combination form in therapeutic effects, it shall be considered a new drug and may be submitted for registration.
- This list specifies special formulations that have not yet been produced domestically: freeze-dried powder for injection, effervescent tablets, sustained-release tablets, controlled-release tablets, suppositories, and special formulations for children.
- This decision replaces Decision No. 6075/2003/QD-BYT of the Minister of Health.
🌐 이 문서의 사회적 영향
- Positive impact: Reducing the risk of using unsafe drugs, protecting public health.
- Negative impact: Causing difficulties for manufacturers wishing to register new drugs, increasing product development costs.
❓ 자주 묻는 질문
To which active substances does this decision apply?
This decision stipulates a list of seven active substances not accepting new registration and re-registration applications.
If a drug contains an active substance listed herein, can a registration application be submitted?
For single substances or combinations, no application shall be accepted. However, if there is clinical trial data proving the superiority of the combination form in therapeutic effects, it shall be considered a new drug and may be submitted for registration.
What special formulations are included in this list?
This list specifies special formulations: freeze-dried powder for injection, effervescent tablets, sustained-release tablets, controlled-release tablets, suppositories, and special formulations for children.
Which decision does this decision replace?
This decision replaces Decision No. 6075/2003/QD-BYT of the Minister of Health.
When does this decision come into effect?
This decision shall take effect fifteen days from the date of publication in the Official Gazette.
전문
DECISION OF THE MINISTER OF HEALTH
Regarding the issuance of the List of active ingredients and dosage forms
not accepting new registration and re-registration applications for foreign drugs
THE MINISTER OF HEALTH
Pursuant to the Law on Health Care for the People dated July 11, 1989;
Pursuant to the Pharmaceutical Regulations for Prevention and Treatment issued pursuant to Decree No. 23/HĐBT dated January 24, 1991 of the Council of Ministers of the Socialist Republic of Vietnam;
Pursuant to Decree No. 49/2003/NĐ-CP dated May 15, 2003 of the Government stipulating the functions, tasks, powers, and organizational structure of the Ministry of Health;
At the proposal of the Director of the Drug Administration of Vietnam under the Ministry of Health,
DECISION:
Article 1. Issuing the List of seven active ingredients and dosage forms for which new registration and re-registration applications for foreign drugs will not be accepted (the List is attached).
Article 2. The List prescribed in Article 1 of this Decision shall not apply to drugs containing active ingredients invented by the manufacturer, provided that there are relevant documents recognizing such invention.
Article 3. Drugs containing active ingredients listed in the List prescribed in Article 1 of this Decision:
1. In single or combined form shall not have their registration applications accepted.
2. In a new combination of multiple active ingredients, if there is clinical trial data proving the superiority of the therapeutic effect of the combination form, it shall be considered a new drug and its application may be submitted for review.
3. In special dosage forms that have not yet been produced domestically: freeze-dried powder for injection, effervescent tablets, sustained-release tablets, controlled-release tablets, suppositories, and special dosage forms for children may submit applications for review.
Article 4. This Decision shall take effect fifteen days from the date of publication in the Official Gazette and revoke the List of active ingredients and dosage forms for which new registration and re-registration applications for foreign drugs were not accepted, as issued by Decision No. 6075/2003/QĐ-BYT dated November 24, 2003 of the Minister of Health.
Article 5. You are hereby notified: Heads of the Office, Director of the Drug Administration of Vietnam, Heads of Departments under the Ministry of Health, Inspector General; Heads of units directly under the Ministry of Health, Directors of Provincial Health Services, Municipalities directly under the Central Government, Health Sector Heads, and Heads of related units are responsible for implementing this Decision./.
관계도
문서를 클릭하면 열립니다. 빨간 테두리=효력을 변경하는 관계.